These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12161852

  • 1. Directly observed antiretroviral therapy for injection drug users with HIV infection.
    Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F.
    AIDS Read; 2002 Jul; 12(7):305-7, 312-6. PubMed ID: 12161852
    [Abstract] [Full Text] [Related]

  • 2. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A.
    Clin Infect Dis; 2007 Aug 01; 45(3):370-6. PubMed ID: 17599317
    [Abstract] [Full Text] [Related]

  • 3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 4. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS.
    HIV Med; 2008 Aug 15; 9(7):503-7. PubMed ID: 18484977
    [Abstract] [Full Text] [Related]

  • 5. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
    Tyndall MW, McNally M, Lai C, Zhang R, Wood E, Kerr T, Montaner JG.
    Int J Drug Policy; 2007 Aug 15; 18(4):281-7. PubMed ID: 17689376
    [Abstract] [Full Text] [Related]

  • 6. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE, Mitty JA, Bazerman LB, Singh K, McKenzie M, Flanigan T.
    Clin Infect Dis; 2004 Jun 01; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT, Kolber MA, Brill M, Tanner T, Campo R, Rodriguez A, Chu HM, Garg V.
    HIV Med; 2004 Sep 01; 5(5):364-70. PubMed ID: 15369512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.
    Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD.
    Clin Infect Dis; 2004 Apr 15; 38(8):1167-74. PubMed ID: 15095224
    [Abstract] [Full Text] [Related]

  • 10. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR.
    J Infect Dis; 2004 Sep 15; 190(6):1046-54. PubMed ID: 15319852
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct 15; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group.
    Antivir Ther; 2005 Oct 15; 10(1):53-61. PubMed ID: 15751763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Stein MD, Urdaneta ME, Clarke J, Maksad J, Sobota M, Hanna L, Markson LE.
    J Addict Dis; 2000 Oct 15; 19(1):85-94. PubMed ID: 10772605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.